183 related articles for article (PubMed ID: 2087939)
1. Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.
Barbagallo CM; Averna MR; Amato S; Marino G; Labisi M; Rao AC; Barbagallo M; Cupidi GF; Notarbartolo A
Acta Diabetol Lat; 1990; 27(4):371-7. PubMed ID: 2087939
[TBL] [Abstract][Full Text] [Related]
2. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.
Sarlund H; Laakso M; Voutilainen E; Penttilä I; Pyörälä K
Atherosclerosis; 1991 Jan; 86(1):17-29. PubMed ID: 2064632
[TBL] [Abstract][Full Text] [Related]
3. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
[TBL] [Abstract][Full Text] [Related]
6. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
Siegel RD; Cupples A; Schaefer EJ; Wilson PW
Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.
Hu D; Jablonski KA; Sparling YH; Robbins DC; Lee ET; Welty TK; Howard BV
Ann Epidemiol; 2002 Feb; 12(2):79-85. PubMed ID: 11880214
[TBL] [Abstract][Full Text] [Related]
8. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
9. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
Averna MR; Barbagallo CM; Di Paola G; Labisi M; Pinna G; Marino G; Dimita U; Notarbartolo A
Biol Neonate; 1991; 60(3-4):187-92. PubMed ID: 1797121
[TBL] [Abstract][Full Text] [Related]
10. Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.
Schauer UJ; Pissarek D; Panzram G
Acta Diabetol Lat; 1989; 26(1):35-42. PubMed ID: 2501960
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
12. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
[TBL] [Abstract][Full Text] [Related]
13. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
14. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
15. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
Oyelola OO; Ajayi AA; Babalola RO; Stein EA
J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
[TBL] [Abstract][Full Text] [Related]
17. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
Rasouli M; Kiasari AM
Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
[TBL] [Abstract][Full Text] [Related]
18. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships.
Mendoza SG; Zerpa A; Velazquez E; Schwarzenberg A; Hynd B; Kashyap ML; Laskarzewski P; Glueck CJ
Int J Obes; 1986; 10(6):427-41. PubMed ID: 3100468
[TBL] [Abstract][Full Text] [Related]
19. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.
Rönnemaa T; Laakso M; Kallio V; Pyörälä K; Marniemi J; Puukka P
Am J Epidemiol; 1989 Oct; 130(4):632-45. PubMed ID: 2773912
[TBL] [Abstract][Full Text] [Related]
20. Magnitude of lipoprotein (a) in diabetes mellitus.
Khan MA; Baseer A
J Pak Med Assoc; 1998 Jan; 48(1):11-3. PubMed ID: 9610080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
